Ashkon Software



NXTM - NxStage Medical, Inc.

NxStage Medical, Inc. logo NxStage Medical, Inc., trading under the ticker symbol NXTM, was a medical technology company that developed and marketed products for the treatment of kidney disease and other chronic conditions. The company was headquartered in Lawrence, Massachusetts.

NxStage Medical's products and solutions included hemodialysis systems, peritoneal dialysis systems, and other products and accessories used in the treatment of kidney disease. The company's mission was to improve the quality of life for patients with kidney disease by providing innovative products and services that enabled more frequent and convenient dialysis treatments.

In 2018, NxStage Medical was acquired by Fresenius Medical Care, a global provider of dialysis products and services, for approximately $2 billion, and the company was delisted from the NASDAQ stock exchange.

Prior to its acquisition, as of its most recent financial filings, NxStage Medical had revenues of approximately $394 million and employed over 3,000 professionals across its various operations worldwide. The company faced competition from other medical technology companies operating in the kidney disease and dialysis products industries.

Investors who held NXTM stock should have received compensation from the acquisition. Investors who are interested in the medical technology industry may want to research other publicly traded companies in the sector, evaluate their financial performance, competitive position, and growth




Copyright © 2000-2023, Ashkon Software LLC
Privacy Policy | Refund Policy | Disclaimer